chrisvoncsefalvay/vaers-outcomes huggingface dataset:
temperature excursion involving PROQUAD; This spontaneous report was received from a nurse referring to a patient of unknown age or gender. The patient's medical conditions, alletgies or concomitant therapies were not reported.  On 27-JAN-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) 0.5 ml, lot # T025510, expiration date 23-JAN-2022, for prophylaxis (route of administration, and anatomical site of injection were not reported), with a temperature excursion or 8.3F and 8.1F, time frame 5 minutes and 5 minutes respectively, there was no previous temperature excursion and recorded by a digital data logger.   This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-2101USA013383:
Pharmacy provided medical center with COVID vaccines in order to conduct a vaccine clinic on 2/22/2021. After review and data entry, it was found that an incorrect birthdate was documented by medical center for patient. Medical center confirmed the correct date of birth when called for clarification. With further investigation, it was concluded that the patient had received a third dose of the COVID vaccine today 2/22/2021.
Chills, cough, headache on the evening of the vaccine turning to fever and chills, headache, cough, and body aches early this morning.  Today, same symptoms with fatique
The patient and her spouse report that the vaccination went fine and they left the pharmacy after the 15 minute waiting period and drove home.  Somewhere between about 45 to 60 minutes after the vaccine, the patient reports that she fell at home.  She reports hitting her head and her chest and hurting her knee during the fall.  Her spouse reports patient then went to lay in bed "for a while".  Patient does not remember putting herself to bed.  She has not sought treatment and says she is improving as far as her chest and knee injuries go.
I starting having wheezing every single day since my shot in February.  My wheezing has gotten so bad.  I went to see my doctor twice since then.  I had a PST done.
Pt recv vax on 10/21/98; on 10/23/98 pt exp LA erythema; tx=ice
was well a/DTP given that evening pt became pale & listless subsequently devel a fever to 104; seen the following day & was alert, active & in no distress nl exam then; subsequently developed sxs again, hospitalized overnight;
Red rash at injection site developed 7 days after Rash is approximately 1inch around injection site
The patient was administered an expired Boostrix vaccine. It was not realized the vaccine was expired till after the patient was given the vaccine and left the pharmacy. The date administered was 10/14/2022. The expiration date of the vaccine was 10/08/2022.  I will reach out to the patient and inform him of the error. I will refund the patient any cost the vaccine cost him. I will reach out to GSK for information if he will need another dose or another treatment.
Client presented for 2 dose of Modern Covid-19, and it was discovered that she was underage for the Moderna vaccine. Client is 17 and Moderna Covid-19 is approved for those 18 years and up. The error was caught before the 2nd vaccine was given, but it was determined by our Medical Director to continue with the Moderna product for dose 2.  Parent aware and consented.
fever; chills; This is a spontaneous report from a contactable consumer (patient).  A 29-year- old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration administered on arm left on an unspecified date (Batch/Lot number was not reported) as 1st dose, single for COVID-19 immunization.  Medical history and concomitant medications were not reported. One week after receiving the vaccine, the patient later experience fever and chills. It was reported that the chills that began at night and lasted until early afternoon (as reported). No treatment was received for the events. The patient was not diagnosed with COVID-19 prior to vaccination and not tested for COVID-19 since the vaccination. The patient recovered from the events on unknown date. Patient thought it was not related to the vaccine.   No follow-up attempts are possible, information about lot/batch number cannot be obtained; Sender's Comments: Based on the information available and reported non-relatedness, contributory role of the suspect BNT162B2 can be excluded for pyrexia and chills. Since they could be concurrent condition.
Really bad diarrhea after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Really bad diarrhea after 1st dose) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced DIARRHOEA (Really bad diarrhea after 1st dose). At the time of the report, DIARRHOEA (Really bad diarrhea after 1st dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medication information was reported. Patient reported that she was shopping in the grocery store where she got the shot, and about 25 minutes after the vaccine, experienced really bad diarrhea. She stated that  this is a change for her as she is usually constipated and that the diarrhea happened just that one time.
fever; chills; aches; headache; fatigue; loss of appetite; Dulled taste; patient received the first dose on 12Jan2021 and the second dose was on 29Jan2021; This is a spontaneous report from a contactable consumer (patient). A 29-year-old non-pregnant female patient received her second dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: El9362; expiration date: unknown) at vaccination age of 29-year-old via an unspecified route of administration in the left arm on 29Jan2021 16:45 at a single dose for covid-19 immunization. Medical history included hypothyroidism, PCOS (polycystic ovarian syndrome) and penicillin allergy. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included levothyroxine, metformin and vitamin nos (MULTIVITAMINS). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: Ek4176) at vaccination age of 29-year-old via an unspecified route of administration in the left arm on 12Jan2021 16:45 at a single dose for covid-19 immunization but had lump on neck, sore arm, diarrhea starting day 3 through today and sore rib. The patient received the most recent COVID-19 vaccine in a hospital. It was reported that the patient received the first dose on 12Jan2021 and the second dose was on 29Jan2021. On an unspecified date after the second dose, the patient had fever, chills, aches, headache, fatigue, loss of appetite and dulled taste. It was unknown if the patient received treatment for the adverse events and events were considered as non-serious. The adverse events resulted in a doctor or other healthcare professional office/clinic visit. The patient has not been tested for COVID-19 since the vaccination. The outcome of the events was recovering.
This is a spontaneous report received from a contactable other health professional (patient). A 32-year-old non pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN5318) via an unspecified route of administration in the left arm on 29Jan2021 at 08:45 (at the age of 32-year-old) as a single dose for COVID-19 immunization in hospital. The patient had no medical history and was not allergic to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ascorbic acid (VIT C), Vitamin d nos, Zinc, D-mannose and neuro effect within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Jan2021 after about 1 hour of vaccination, the patient experienced itching for about 24 hours and then developed a rash on 04Feb2021 (1 week after vaccination) starting on arms and side stomach. Since then, it had spread to upper back, neck, face and legs. The rash was not itchy. Patient did not receive any treatment for the events. The outcome of the event itching was recovered on an unspecified date in Jan2021, and event developed a rash 1 week after vaccination starting on arms and side stomach. Since then, it has spread to upper back, neck, face and legs was not recovered. Follow-up attempts are completed. No further information is expected.
Flu-like symptoms (2 days), headaches (3 days), soreness (2 days) and swollen lymph nodes in the neck (5 days).  Treatment was Tylenol and ibuprofen.  Doctor did not prescribe anything due to he suspected it was in result of the COVID19 shot.
Age inappropriate dose was given by LPN.  Child was 11 years old and received the vaccine for 12 and above.  As of this time no adverse reactions noted.
Noted feet was causing to feet and felt claves of legs getting tight.  When he arrived home at 8:00 pm ha noted significant swelling of both ankles, esp on LLE.  Rash significantly on legs but noticed elsewhere on body.  Also had arthralgia of lower extremities.  Went to local ER.  Give pain med, antibiotics, and instructed to stop Plavix that he takes for his Raynaud's.  Reevaluated in Er on 10-19-09 for progression of rash on legs and lower torso, severe H/A migraine in nature with N/V. Then had follow-up appt with PCP on 10/19/09 and rhuematology on 10-19-09 also.  Diagnosed with progressive vasculitis, given prednisone and stopped Plavix and claritin for itching should that have occured. 11/6/2009 Ed records from 10/15 and 10/19/2009. Patient with c/o's rash, edema of lower extremities, arthralgias and headaches. Tx: IV fentanyl and Zofran. To f/up with Rheumatologist. DC DX: Hypersensitivity vasculitis.
First Moderna Covid Vaccine administered in the right deltoid. Patient felt fine, and ambulated to the observation area. She took a seat, and then shortly thereafter passed out in her chair. Nursing responded; vitals were taken, and recorded in her chart. Patient was transported via wheelchair to the Urgent Care within the facility. Patient was observed, assessed by a Physician's Assistant and released home without further incident. No medications or diagnostic tests were ordered at the time.
Headache, Myalgia, Arthralgia, UrticariaPruritus, NauseaVomiting, arm went numb to fingertips immediate after injection, arm swelling and immediate pain. next day woke to h/a, nausea, fatigue, myalgia, severe arthralgia, itching at injection site, sore throat and sweats.
transverse myelitis w/paraplegia, sensory loss to T3 & bowel;MRI head, C-spine, T-spine, L-S spine LP;pt transferred to nurse for tertiary care facility;
A 59yo female with PMH of HTN, Hyperlipidemia, DM II, Tobacco Use, Vitamin D deficiency and Cerebrovascular Accident May 4, 2021 Advice line call documentation indicated patient had Moderna Covid - 19 vaccine on April 4, 2021 and reported an adverse reaction of dizziness x 2 days The patient presented to the VA ER on May 4, 2021 and was reported with a historical Moderna Covid- 19 induced ADR of weakness by the documenting nurse on May 6, 2021.
Chills, sweats, arm pain, headache, fatigue, nausea in first 24 hours. Right arm axillary lymph node pain and swelling from 8 hours after injection to current (40 hours after injection).
Arm soreness began night of injection. Next day I experienced fatigue, low-grade fever, muscle aches, nausea. By second day I was feeling fine/all symptoms abated.
Fever of about 102 degrees for about 24 hours; Pain in the armpit close to the injection site; This is a spontaneous report from a contactable consumer. A 66-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the arm left on an unknown date (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was unknown. It was unknown if the patient had any known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19 on an unspecified date. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, it was unknown if the patient had not been tested for COVID-19. On an unknown date in May2021, the patient experienced a fever of about 102 degrees for about 24 hours, and pain in the armpit close to the injection site. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of the events fever of about 102 degrees for about 24 hours, and pain in the armpit close to the injection site was recovered on an unknown date. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. Amendment: This follow-up report is being submitted to amend previous information: Patient's city, state added in patient tab, vaccine Start Date/Time and Stop Date/Time, AE Stop Date/Time removed as not reported, relevant information updated in narrative, final sentence updated from "The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up" to "No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected".
On 08/02 my husband tested positive. On 08/03 woke up with symptoms and tested negative. Symptoms worsened throughout the day and developed a fever. Tested on 08/4-08/5 negative. Went into doctor and tested negative on rapid and they performed PCR test. Symptoms continued to worsen and began have shortness of breath. PCR test returned negative while I was in ER. Performed another antigen and finally tested positive. Was sent home on nebulizer and Paxolovid. Took OTC meds to treat symptoms. Woke up early morning 08/8 unable to breath. Went to hospital and was given breathing treatment. Was admitted to hospital and released on 08/11.
Weakness, Tiredness, Dizziness , lack of appetite.  Symptoms began two days after shot and continued with increasing severity on the following days.  Very weak by fourth day after the symptoms began.
Back pain (used heat; it lasted 5 hours and was gone the next day) Chills/achy (used Advil, lasted 24 hours, stared the day after my second dose) Hard, red itchy patch on arm just below injection site (started the day after second dose; still experiencing this symptom)
Redness and itching at the site of injection that started the night of the injection  No fever or systemic symptoms reported Applied topical calamine and the redness improved by day 3-4
Inconsolable crying. Injection site soreness. Injection in leg, sudden onset of pain with limping and crying.
After lunch a steak and having one beer and two glasses  of red wine I felt nausea and stared vomiting after that OK and went to sleep
Pfizer COVID vaccines 1/30/21 and 2/20/21.  Hospitalization 10/13/21
legs have been swelling where they can barely walk in the morning; Hands, are very hard  ever since  second shot; hand swelling after second dose.; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (legs have been swelling where they can barely walk in the morning), LIMB DISCOMFORT (Hands, are very hard  ever since  second shot) and PERIPHERAL SWELLING (hand swelling after second dose.) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 037A21B) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, the patient experienced PERIPHERAL SWELLING (legs have been swelling where they can barely walk in the morning), LIMB DISCOMFORT (Hands, are very hard  ever since  second shot) and PERIPHERAL SWELLING (hand swelling after second dose.). At the time of the report, PERIPHERAL SWELLING (legs have been swelling where they can barely walk in the morning), LIMB DISCOMFORT (Hands, are very hard  ever since  second shot) and PERIPHERAL SWELLING (hand swelling after second dose.) outcome was unknown.            No concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Reporter demographic details was added, patient Date of birth  and gender added dose 1 & dose 2 information was added
Two days after Moderna, started having really bad heartburn, then her body started tingling and feeling numb. She went to the ER and they ran an EKG and referred her to cardiovascular specialists. Found that she has Afib and is currently wearing a heart monitor.
TIRED; ITCHINING ON ARM AND WAISTLINE; RED PATCHES ABOUT THE SIZE OF A GRAPEFRUIT BETWEEN ELBOW AND SHOULDER ON BOTH ARMS AND THREE RED PATCHES ABOUT THE SIZE OF QUARTER; HEADACHE; EXTREME BODY ACHES; This spontaneous report received from a patient concerned a 66 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included penicillin allergy, kidney stone, gall bladder problem, non-smoker, and no alcohol use, and other pre-existing medical conditions included the patient had no immune disorder, no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 203A21A expiry: UNKNOWN) dose was not reported, administered on 06-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-MAY-2021, the subject experienced itching on arm and waistline. On 11-MAY-2021, the subject experienced red patches about the size of a grapefruit between elbow and shoulder on both arms and three red patches about the size of quarter. On an unspecified date, the subject experienced extreme body aches, headache, and tired. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from extreme body aches, and headache, had not recovered from red patches about the size of a grapefruit between elbow and shoulder on both arms and three red patches about the size of quarter, and itching on arm and waistline, and the outcome of tired was not reported. This report was non-serious.
Exposure during preganacy; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Exposure during preganacy) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 004M20A) for COVID-19 vaccination.     The patient's past medical history included Miscarriage (Spontaneous abortion).   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 20-May-2021. On 27-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Exposure during preganacy). On 24-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Exposure during preganacy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Sep-2020, Pregnancy test: positive (Positive) Positive. On 16-Sep-2020, Ultrasound testes: normal (normal) normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment details not provided.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 37 year old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
SI-Joints locked up; SI-Joints in excruciating pain; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the right arm on 13Apr2021 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included PSA-ankylosing spondylitis and spondylitis. It was reported that the patient had previously been diagnosed with Psoriatic arthritis (PSA) and it had been effecting his SI Joints back in 2012- 2018. Been in a remission stage since late 2018. The patient had allergy to Humira- Biologics. Concomitant medications include steroid injection (MANUFACTURER UNKNOWN) in right knee on 12Apr2021. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 23Mar2021 at 08:45 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 morning around 02:30 the patient woke up with both SI-Joints locked up and in excruciating pain. The patient enquired if the medication could identify another area that needed attention. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcomes of the events SI-Joints locked up and in excruciating pain were not recovered.  No follow-up attempts are needed. No further information is expected.
rash only on left side; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash only on left side) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMIN 15 and LISINOPRIL for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (rash only on left side). At the time of the report, RASH (rash only on left side) outcome was unknown.            Patient reported rash only on the left side after receiving the second dose and it lasted for two weeks.  Treatment details included counter cream for rash.     This case was linked to US-MODERNATX, INC.-MOD-2021-148564 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Follow up received on 09-JUL-2021. No new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-148564:crosslinked
Subsequent to receiving vax the pt experienced a breakthrough rash with a few vesicles on the right shoulder and under her chin. The pt sought unspecified medical treatment. Additional information has been requested.
PT FELT WEAK AND DIZZY WANTWED TO LAY DOWN ON FLOOR. FELT A LITTLE BETTER AFTER  LAYONG ON FLOOR. KET T ON FLOOR FOR 15MIN THEN PT SAT ON FLOOR FOR ADDITIONAL 15MIN/ NO LONGER DIZZY.